Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
- PMID: 1312670
- PMCID: PMC369619
- DOI: 10.1128/mcb.12.4.1755-1763.1992
Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
Abstract
Irradiated mice reconstituted with bone marrow cells infected with a retrovirus carrying the bcr-abl oncogene of human chronic myeloid leukemia are subject to a range of neoplastic hematopoietic diseases, both myeloid and lymphoid. Comparison of DBA/2 and C57BL/6 mice has revealed a marked strain difference in susceptibility to the various tumor types. The present study, performed with BALB/c mice, indicates that the kinetics and nature of the induced disease can be modulated by the infection procedure, as well as the genetic background, and that retroviral regulatory sequences may influence the outcome. A distinctive clonal myeloproliferative disorder, somewhat akin to chronic myeloid leukemia but with prominent erythroid and mast cell components, as well as granulocytic excess, was characterized.
Similar articles
-
Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice.Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3755-9. doi: 10.1073/pnas.90.8.3755. Proc Natl Acad Sci U S A. 1993. PMID: 8475126 Free PMC article.
-
Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia.Blood. 1998 Nov 15;92(10):3829-40. Blood. 1998. PMID: 9808576
-
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.Blood. 1998 Nov 15;92(10):3780-92. Blood. 1998. PMID: 9808572
-
Disease progression in a murine model of bcr/abl leukemogenesis.Leuk Lymphoma. 1993;11 Suppl 1:239-42. doi: 10.3109/10428199309047893. Leuk Lymphoma. 1993. PMID: 8251903 Review.
-
Models of chronic myeloid leukemia.Curr Oncol Rep. 2001 May;3(3):228-37. doi: 10.1007/s11912-001-0055-y. Curr Oncol Rep. 2001. PMID: 11296133 Review.
Cited by
-
Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy.Mol Cell Biol. 1999 Oct;19(10):6918-28. doi: 10.1128/MCB.19.10.6918. Mol Cell Biol. 1999. PMID: 10490629 Free PMC article.
-
BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.J Virol. 1993 Oct;67(10):6033-46. doi: 10.1128/JVI.67.10.6033-6046.1993. J Virol. 1993. PMID: 8396667 Free PMC article.
-
Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells.Cancer Sci. 2010 Jul;101(7):1577-81. doi: 10.1111/j.1349-7006.2010.01584.x. Epub 2010 Apr 5. Cancer Sci. 2010. PMID: 20491777 Free PMC article. Review.
-
The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl.Mol Cell Biol. 2001 Feb;21(3):840-53. doi: 10.1128/MCB.21.3.840-853.2001. Mol Cell Biol. 2001. PMID: 11154271 Free PMC article.
-
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.J Exp Med. 1999 May 3;189(9):1399-412. doi: 10.1084/jem.189.9.1399. J Exp Med. 1999. PMID: 10224280 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
